Free Trial
→ Elon's next millionaires start October 24? (From Behind the Markets) (Ad)tc pixel Free INTT Stock Alerts

inTEST (INTT) Financials

inTEST logo
$12.98 -1.52 (-10.49%)
Closing price 03:59 PM Eastern
Extended Trading
$13.07 +0.09 (+0.70%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for inTEST

Annual Income Statements for inTEST

This table shows inTEST's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Consolidated Net Income / (Loss)		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Net Income / (Loss) Continuing Operations		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Total Pre-Tax Income 		2.58 4.21 3.84 5.04 2.60 -1.23 8.40 10 11 3.45 -3.22
Total Operating Income		 2.56 4.15 3.61 5.18 2.55 -1.22 8.46 11 10 3.39 -3.73
Total Gross Profit		 19 20 35 39 29 24 41 53 57 55 49
Total Revenue		 39 40 67 79 61 54 85 117 123 131 114
Operating Revenue		 39 40 67 79 61 54 85 117 123 131 114
Total Cost of Revenue		 20 20 32 39 31 30 44 63 66 75 65
Operating Cost of Revenue		 20 20 32 39 31 30 44 63 66 75 65
Total Operating Expenses		 16 16 31 34 27 25 33 43 47 52 53
Selling, General & Admin Expense		 12 13 20 22 21 19 27 35 39 41 39
Research & Development Expense		 3.94 3.66 4.30 4.91 4.96 5.07 5.53 7.53 7.62 8.55 9.44
Amortization Expense		 - - - - - - - - - 2.55 3.35
Restructuring Charge		 - - - - 0.24 1.29 - - - 0.00 0.85
Total Other Income / (Expense), net		 0.02 0.06 0.23 -0.14 0.06 -0.01 -0.06 -0.58 0.61 0.06 0.50
Interest Expense		 - - - - - - 0.09 0.64 0.68 0.85 0.45
Other Income / (Expense), net		 0.02 0.06 0.23 -0.14 0.06 -0.01 0.03 0.06 1.29 0.91 0.95
Income Tax Expense		 0.72 1.55 2.86 2.01 0.28 -0.34 1.12 1.68 1.71 0.56 -0.70
Basic Earnings per Share		 $0.18 $0.26 $0.09 $0.29 $0.22 ($0.09) $0.70 $0.79 $0.82 $0.24 ($0.21)
Weighted Average Basic Shares Outstanding		 10.47M 10.31M 10.28M 10.35M 10.37M 10.26M 10.46M 10.67M 11.46M 12.15M 12.20M
Diluted Earnings per Share		 $0.18 $0.26 $0.09 $0.29 $0.22 ($0.09) $0.68 $0.78 $0.79 $0.24 ($0.21)
Weighted Average Diluted Shares Outstanding		 10.49M 10.33M 10.34M 10.38M 10.39M 10.26M 10.73M 10.86M 11.78M 12.24M 12.20M
Weighted Average Basic & Diluted Shares Outstanding		 10.50M 10.40M 10.47M 10.57M 10.43M 10.70M 10.96M 11.12M 12.16M 12.37M 12.50M

Quarterly Income Statements for inTEST

This table shows inTEST's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79 0.47
Consolidated Net Income / (Loss)		 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79 0.47
Net Income / (Loss) Continuing Operations		 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79 0.47
Total Pre-Tax Income 		1.57 0.79 0.30 0.57 1.80 -2.79 -0.58 -1.23 1.38 0.98 0.25
Total Operating Income		 1.11 0.49 0.34 0.49 2.08 -2.88 -0.93 -1.19 1.28 0.95 0.36
Total Gross Profit		 12 13 14 14 15 11 12 11 15 15 14
Total Revenue		 28 30 34 30 37 27 28 26 33 34 35
Operating Revenue		 28 30 34 30 37 27 28 26 33 34 35
Total Cost of Revenue		 15 17 20 16 22 16 16 15 18 18 21
Operating Cost of Revenue		 15 17 20 16 22 16 16 15 18 18 21
Total Operating Expenses		 11 13 13 14 12 14 13 12 14 14 14
Selling, General & Admin Expense		 9.41 10 10 10 10 10 9.59 8.89 10 10 11
Research & Development Expense		 1.93 1.98 2.22 2.18 2.17 2.45 2.25 2.34 2.41 2.59 2.50
Amortization Expense		 - 0.60 0.90 0.94 - 0.81 0.85 0.84 0.84 0.78 0.70
Restructuring Charge		 - 0.00 0.00 0.00 - 0.31 0.22 0.12 0.21 0.74 0.03
Total Other Income / (Expense), net		 0.46 0.30 -0.04 0.08 -0.28 0.09 0.34 -0.03 0.10 0.02 -0.11
Interest Expense		 0.15 0.14 0.25 0.22 0.23 0.15 0.12 0.10 0.08 0.08 0.06
Other Income / (Expense), net		 0.61 0.44 0.21 0.30 -0.04 0.24 0.46 0.06 0.19 0.10 -0.05
Income Tax Expense		 0.11 0.13 0.07 0.07 0.30 -0.46 -0.08 -0.29 0.13 0.19 -0.23
Basic Earnings per Share		 $0.12 $0.06 $0.02 $0.04 $0.12 ($0.19) ($0.04) ($0.08) $0.10 $0.06 $0.04
Weighted Average Basic Shares Outstanding		 11.46M 12.03M 12.23M 12.19M 12.15M 12.18M 12.22M 12.21M 12.20M 12.25M 12.31M
Diluted Earnings per Share		 $0.11 $0.05 $0.02 $0.04 $0.13 ($0.19) ($0.04) ($0.08) $0.10 $0.06 $0.04
Weighted Average Diluted Shares Outstanding		 11.78M 12.16M 12.33M 12.25M 12.24M 12.18M 12.22M 12.21M 12.20M 12.42M 12.58M
Weighted Average Basic & Diluted Shares Outstanding		 12.16M 12.49M 12.52M 12.37M 12.37M 12.49M 12.48M 12.48M 12.50M 12.56M 12.83M

Annual Cash Flow Statements for inTEST

This table details how cash moves in and out of inTEST's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 2.58 2.90 -15 4.57 -10 2.67 11 -6.62 31 -25 -1.77
Net Cash From Operating Activities		 3.50 4.29 7.24 11 -8.41 3.25 11 -1.39 16 3.82 7.32
Net Cash From Continuing Operating Activities		 3.50 4.29 7.24 11 -8.41 3.25 11 -1.39 16 3.82 7.32
Net Income / (Loss) Continuing Operations		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Consolidated Net Income / (Loss)		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Depreciation Expense		 0.75 0.60 1.78 1.87 3.19 3.17 3.15 4.73 4.68 5.39 6.80
Non-Cash Adjustments To Reconcile Net Income		 0.72 0.64 5.96 12 -11 0.56 0.71 1.41 1.08 1.21 0.01
Changes in Operating Assets and Liabilities, net		 0.16 0.39 -1.47 -6.43 -3.29 0.41 -0.30 -16 1.10 -5.67 3.04
Net Cash From Investing Activities		 -0.60 -0.34 -23 -6.34 -0.62 -0.65 -21 -1.17 -1.29 -20 -1.63
Net Cash From Continuing Investing Activities		 -0.60 -0.34 -23 -6.34 -0.62 -0.65 -21 -1.17 -1.29 -20 -1.63
Purchase of Property, Plant & Equipment		 -0.60 -0.34 -0.75 -2.21 -0.62 -0.66 -0.99 -1.37 -1.29 -1.32 -1.63
Acquisitions		 - 0.00 -22 -4.12 - 0.00 -20 -0.18 0.00 -19 0.00
Net Cash From Financing Activities		 -0.16 -0.98 -0.06 0.00 -1.14 -0.07 22 -3.73 16 -8.64 -8.23
Net Cash From Continuing Financing Activities		 -0.16 -0.98 -0.06 0.00 -1.14 -0.07 22 -3.73 16 -8.64 -8.23
Repayment of Debt		 - - - - 0.00 -5.63 -0.40 -3.96 -4.10 -7.84 -8.35
Repurchase of Common Equity		 -0.16 -0.98 -0.06 0.00 -1.14 -0.07 - - 0.00 -1.04 0.00
Other Financing Activities, net		 - - - - - - 1.63 0.23 0.47 0.24 0.13
Other Net Changes in Cash		 - - - - -0.08 0.14 -0.28 -0.32 0.16 -0.56 0.77
Cash Interest Paid		 - - - - - - - - 0.69 0.88 0.46
Cash Income Taxes Paid		 0.79 0.64 3.47 2.86 0.54 0.05 1.32 3.92 3.24 3.07 0.19

Quarterly Cash Flow Statements for inTEST

This table details how cash moves in and out of inTEST's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 3.58 -18 -6.96 -2.40 1.86 2.22 -3.66 2.71 -3.04 -2.37 6.42
Net Cash From Operating Activities		 4.68 2.08 -5.09 4.25 2.59 5.54 -0.69 3.49 -1.02 -3.32 6.32
Net Cash From Continuing Operating Activities		 4.68 2.08 -5.06 4.22 2.59 5.54 -0.69 3.49 -1.02 -3.32 6.32
Net Income / (Loss) Continuing Operations		 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79 -0.13
Consolidated Net Income / (Loss)		 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79 -0.13
Depreciation Expense		 1.17 1.28 1.52 1.66 0.92 1.74 1.57 1.70 1.79 1.64 1.62
Non-Cash Adjustments To Reconcile Net Income		 0.14 0.08 1.49 0.51 0.43 -0.09 -0.10 0.05 0.15 0.69 -0.18
Changes in Operating Assets and Liabilities, net		 1.92 0.05 -8.31 1.56 -0.27 6.21 -1.65 2.68 -4.20 -6.44 5.01
Net Cash From Investing Activities		 -0.31 -19 -0.14 -0.51 -0.16 -0.23 -0.46 -0.41 -0.53 -0.64 -0.41
Net Cash From Continuing Investing Activities		 -0.31 -19 -0.14 -0.51 -0.16 -0.23 -0.46 -0.41 -0.53 -0.64 -0.41
Purchase of Property, Plant & Equipment		 -0.31 -0.34 -0.32 -0.51 -0.16 -0.23 -0.46 -0.41 -0.53 -0.64 -0.41
Net Cash From Financing Activities		 -0.97 -0.87 -0.98 -6.31 -0.48 -3.41 -2.20 -1.23 -1.39 1.67 0.62
Net Cash From Continuing Financing Activities		 -0.97 -0.87 -1.06 -6.22 -0.48 -3.44 -2.20 -1.23 -1.39 1.67 0.62
Repayment of Debt		 -1.03 -1.18 -1.95 -4.20 -0.51 -1.03 -2.21 -1.26 -1.43 1.16 -2.27
Other Financing Activities, net		 0.06 0.03 0.04 0.14 0.03 0.01 0.02 0.03 0.04 0.50 2.89
Cash Interest Paid		 - 0.15 0.26 0.23 - 0.14 0.12 0.10 0.09 0.09 0.07
Cash Income Taxes Paid		 0.25 0.10 1.05 -0.01 1.93 0.03 0.11 -0.05 0.10 -0.57 0.02

Annual Balance Sheets for inTEST

This table presents inTEST's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 40 43 62 67 60 62 104 110 135 152 151
Total Current Assets		 34 38 31 36 25 27 52 60 86 79 79
Cash & Equivalents		 26 29 13 18 7.61 10 21 13 45 20 14
Restricted Cash		 - - - - - - 0.00 1.14 - 0.00 3.84
Accounts Receivable		 4.40 5.38 12 11 9.30 8.44 17 21 18 29 26
Inventories, net		 3.52 3.68 4.97 6.52 7.18 7.48 13 23 20 27 32
Prepaid Expenses		 0.64 0.34 0.58 0.68 0.81 0.78 1.48 1.70 2.25 2.65 3.11
Plant, Property, & Equipment, net		 1.11 0.94 1.54 2.72 2.42 2.35 2.69 3.13 3.19 4.46 4.78
Total Noncurrent Assets		 4.61 3.89 30 29 32 33 49 47 46 69 68
Goodwill		 1.71 1.71 14 14 14 14 21 22 22 31 32
Intangible Assets		 1.10 0.88 16 15 14 12 22 19 17 26 25
Noncurrent Deferred & Refundable Income Taxes		 1.25 1.11 - - - - 0.00 0.28 1.44 0.07 0.78
Other Noncurrent Operating Assets		 0.20 0.03 0.03 0.03 4.87 6.42 5.96 6.34 6.00 12 9.89
Total Liabilities & Shareholders' Equity		 40 43 62 67 60 62 104 110 135 152 151
Total Liabilities		 4.06 5.06 23 24 15 17 49 45 39 52 48
Total Current Liabilities		 4.06 5.06 14 21 8.36 8.86 25 27 24 32 36
Short-Term Debt		 - 0.00 5.36 12 - 0.00 4.10 4.10 4.10 7.49 6.06
Accounts Payable		 0.91 1.37 2.03 1.79 1.98 2.42 4.28 7.39 5.52 17 21
Current Deferred Revenue		 - 0.07 0.89 1.26 0.46 0.40 6.04 4.50 3.80 4.99 6.39
Current Deferred & Payable Income Tax Liabilities		 0.03 0.58 1.20 0.70 0.87 0.83 2.02 1.41 1.04 - 0.00
Other Current Liabilities		 0.34 0.17 2.17 1.11 1.80 2.02 2.64 3.21 3.40 1.99 2.10
Total Noncurrent Liabilities		 0.00 0.00 8.79 2.89 6.52 8.42 24 18 14 21 12
Long-Term Debt		 - - - - - 0.00 16 12 7.94 7.54 1.41
Capital Lease Obligations		 - - - - 3.79 6.05 5.25 4.71 3.50 9.02 7.40
Noncurrent Deferred Revenue		 - 0.00 0.44 - - - - 0.00 1.33 1.43 1.06
Other Noncurrent Operating Liabilities		 - 0.00 5.74 0.20 0.46 0.45 1.38 1.49 1.48 2.56 2.07
Commitments & Contingencies		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 36 38 39 43 45 45 55 65 96 100 104
Total Preferred & Common Equity		 36 38 39 43 45 45 55 65 96 100 104
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 36 38 39 43 45 45 55 65 96 100 104
Common Stock		 26 26 26 27 26 27 30 32 55 58 60
Retained Earnings		 9.01 12 13 16 18 17 24 33 42 45 43
Accumulated Other Comprehensive Income / (Loss)		 0.73 0.64 0.88 0.78 0.67 0.89 0.59 0.22 0.41 -2.14 2.46
Other Equity Adjustments		 0.00 - - - 0.00 - - -0.21 - -0.94 -0.96

Quarterly Balance Sheets for inTEST

This table presents inTEST's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 135 160 161 158 148 150 148 151 149
Total Current Assets		 87 85 81 81 75 75 75 80 80
Cash & Equivalents		 42 27 20 18 22 19 16 13 22
Restricted Cash		 0.00 - - - - - 4.87 2.82 0.00
Accounts Receivable		 21 23 30 28 21 23 21 30 27
Inventories, net		 22 31 29 32 28 28 28 30 28
Prepaid Expenses		 2.01 3.87 2.38 3.21 4.09 4.64 5.10 3.34 3.01
Plant, Property, & Equipment, net		 3.14 4.77 4.53 4.57 4.43 4.68 4.72 4.97 4.91
Total Noncurrent Assets		 46 69 75 73 69 70 68 66 64
Goodwill		 22 33 35 32 31 32 32 32 32
Intangible Assets		 17 29 27 28 26 27 26 24 23
Noncurrent Deferred & Refundable Income Taxes		 1.38 0.00 0.00 0.00 0.00 0.00 0.00 0.93 0.75
Other Noncurrent Operating Assets		 5.70 7.17 13 12 11 11 10 9.25 8.60
Total Liabilities & Shareholders' Equity		 135 160 161 158 148 150 148 151 149
Total Liabilities		 41 60 61 58 49 47 46 46 41
Total Current Liabilities		 27 40 36 36 31 31 32 36 32
Short-Term Debt		 4.10 9.63 12 8.27 6.88 6.43 6.53 7.42 5.35
Accounts Payable		 7.30 11 8.28 9.21 17 17 17 19 19
Current Deferred Revenue		 4.40 5.60 5.49 6.98 4.94 5.60 6.56 6.79 5.46
Current Deferred & Payable Income Tax Liabilities		 1.12 0.51 0.00 0.00 - - - 0.73 0.04
Other Current Liabilities		 3.29 4.04 3.80 3.99 2.06 2.10 2.06 2.12 2.14
Total Noncurrent Liabilities		 15 21 25 22 17 16 14 10 9.28
Long-Term Debt		 8.97 11 9.11 7.82 4.95 3.67 2.34 1.12 0.90
Capital Lease Obligations		 3.50 4.64 10 9.65 8.60 8.32 7.90 6.86 6.41
Noncurrent Deferred Revenue		 1.03 1.21 1.26 1.21 1.41 1.37 1.11 0.82 0.42
Other Noncurrent Operating Liabilities		 1.40 2.77 2.58 2.61 2.09 2.23 2.18 1.66 1.56
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 94 99 100 100 99 103 102 104 108
Total Preferred & Common Equity		 94 99 100 100 99 103 102 104 108
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 94 99 100 100 99 103 102 104 108
Common Stock		 54 57 58 57 58 59 59 60 64
Retained Earnings		 41 43 43 44 43 42 41 43 43
Accumulated Other Comprehensive Income / (Loss)		 0.00 0.31 -0.43 0.39 -0.68 2.57 2.39 1.72 1.35
Other Equity Adjustments		 -0.90 -0.93 -0.94 -0.94 -0.95 -0.96 -0.96 -1.00 -1.02

Annual Metrics And Ratios for inTEST

This table displays calculated financial ratios and metrics derived from inTEST's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 10,562,678.00 10,376,770.00 10,413,058.00 10,489,958.00 10,494,761.00 10,529,123.00 10,873,392.00 11,022,949.00 24,326,010.00 - 12,483,433.00
DEI Adjusted Shares Outstanding		 10,562,678.00 10,376,770.00 10,413,058.00 10,489,958.00 10,494,761.00 10,529,123.00 10,873,392.00 11,022,949.00 24,326,010.00 - 12,483,433.00
DEI Earnings Per Adjusted Shares Outstanding		 0.18 0.26 0.09 0.29 0.22 -0.09 0.67 0.77 0.38 - -0.20
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -6.96% 3.44% 66.06% 17.61% -22.79% -11.27% 57.70% 37.64% 5.54% 5.99% -12.90%
EBITDA Growth		 -43.65% 44.02% 16.87% 23.09% -16.16% -66.48% 498.87% 33.33% 5.78% -40.94% -58.48%
EBIT Growth		 -47.38% 62.87% -8.77% 31.40% -48.36% -147.27% 789.76% 26.96% 8.78% -63.33% -164.47%
NOPAT Growth		 -46.40% 41.91% -64.98% 240.06% -27.14% -137.48% 960.71% 21.94% -1.28% -67.82% -191.79%
Net Income Growth		 -45.89% 42.83% -63.32% 211.49% -23.54% -138.54% 913.74% 16.17% 10.41% -69.05% -187.41%
EPS Growth		 -45.45% 44.44% -65.38% 222.22% -24.14% -140.91% 855.56% 14.71% 1.28% -69.62% -187.50%
Operating Cash Flow Growth		 -31.80% 22.58% 68.89% 51.34% -176.69% 138.64% 233.81% -112.81% 1,266.52% -76.42% 91.44%
Free Cash Flow Firm Growth		 -32.13% 21.22% -710.45% 87.24% 41.33% 77.33% -2,991.88% 70.34% 507.66% -356.52% 102.80%
Invested Capital Growth		 -9.43% -8.75% 246.35% 18.71% 10.44% -1.20% 45.79% 20.81% -6.56% 56.35% -3.44%
Revenue Q/Q Growth		 -4.71% 6.16% 15.79% -1.19% -7.36% 2.40% 9.67% 9.41% -3.54% 7.15% -3.22%
EBITDA Q/Q Growth		 -29.06% 56.55% -50.84% 141.66% 32.02% -35.47% 9.01% 32.61% -11.97% 0.75% 7.74%
EBIT Q/Q Growth		 -33.99% 72.42% -61.47% 390.09% 78.48% -854.26% 10.10% 52.99% -16.63% 7.96% -26.17%
NOPAT Q/Q Growth		 -33.63% 59.44% -85.70% 495.95% 176.14% -788.32% 11.29% 51.19% -20.69% 32.70% -27.48%
Net Income Q/Q Growth		 -33.23% 57.28% -85.10% 512.08% 188.09% -528.23% 10.08% 53.72% -16.07% 1.72% -11.52%
EPS Q/Q Growth		 -30.77% 44.44% -85.48% 583.33% 266.67% -550.00% 11.48% 52.94% -19.39% 9.09% -16.67%
Operating Cash Flow Q/Q Growth		 -44.13% 84.83% -6.37% 18.15% -55.85% 3.90% 20.86% -47.92% 17.50% -35.41% -33.04%
Free Cash Flow Firm Q/Q Growth		 -46.20% 123.54% -39.44% 62.12% -159.31% 92.40% -186.00% 87.91% 27.58% 6.95% -88.52%
Invested Capital Q/Q Growth		 -4.62% -13.67% -2.84% -3.78% 11.67% -2.12% 68.83% 4.37% -3.27% -3.82% 2.96%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 48.08% 50.66% 51.93% 50.15% 48.18% 44.78% 48.57% 45.74% 46.21% 42.41% 42.98%
EBITDA Margin		 8.58% 11.95% 8.41% 8.80% 9.56% 3.61% 13.71% 13.28% 13.31% 7.42% 3.54%
Operating Margin		 6.59% 10.31% 5.41% 6.59% 4.20% -2.26% 9.97% 9.18% 8.47% 2.60% -3.27%
EBIT Margin		 6.64% 10.46% 5.75% 6.42% 4.29% -2.29% 10.00% 9.23% 9.51% 3.29% -2.44%
Profit (Net Income) Margin		 4.79% 6.61% 1.46% 3.87% 3.83% -1.66% 8.58% 7.24% 7.58% 2.21% -2.22%
Tax Burden Percent		 72.05% 63.18% 25.40% 60.22% 89.17% 72.71% 86.68% 83.40% 84.56% 83.70% 78.43%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.95% 94.11% 94.21% 80.33% 116.23%
Effective Tax Rate		 27.95% 36.82% 74.60% 39.78% 10.83% 0.00% 13.32% 16.60% 15.44% 16.30% 0.00%
Return on Invested Capital (ROIC)		 17.79% 27.77% 4.57% 9.15% 5.84% -2.10% 14.77% 13.76% 12.83% 3.33% -2.55%
ROIC Less NNEP Spread (ROIC-NNEP)		 17.72% 27.63% 4.25% 10.33% 4.84% -1.06% 46.24% 4.36% 8.48% 2.94% 13.00%
Return on Net Nonoperating Assets (RNNOA)		 -12.49% -20.56% -2.04% -1.76% -0.54% 0.10% -0.15% 0.37% -1.24% -0.39% 0.07%
Return on Equity (ROE)		 5.30% 7.21% 2.53% 7.39% 5.29% -2.00% 14.63% 14.13% 11.59% 2.95% -2.48%
Cash Return on Invested Capital (CROIC)		 27.68% 36.92% -105.82% -7.96% -4.09% -0.89% -22.48% -5.09% 19.61% -40.63% 0.95%
Operating Return on Assets (OROA)		 6.56% 10.16% 7.29% 7.78% 4.10% -2.02% 10.23% 10.08% 9.58% 3.00% -1.83%
Return on Assets (ROA)		 4.73% 6.42% 1.85% 4.68% 3.66% -1.47% 8.78% 7.91% 7.63% 2.01% -1.66%
Return on Common Equity (ROCE)		 5.30% 7.21% 2.53% 7.39% 5.29% -2.00% 14.63% 14.13% 11.59% 2.95% -2.48%
Return on Equity Simple (ROE_SIMPLE)		 5.18% 7.03% 2.48% 7.08% 5.18% -2.00% 13.28% 13.03% 9.70% 2.90% 0.00%
Net Operating Profit after Tax (NOPAT)		 1.85 2.62 0.92 3.12 2.27 -0.85 7.33 8.94 8.83 2.84 -2.61
NOPAT Margin		 4.75% 6.51% 1.37% 3.97% 3.75% -1.58% 8.64% 7.65% 7.16% 2.17% -2.29%
Net Nonoperating Expense Percent (NNEP)		 0.06% 0.14% 0.31% -1.18% 1.00% -1.04% -31.47% 9.40% 4.36% 0.39% -15.56%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 7.89% 2.29% -2.20%
Cost of Revenue to Revenue		 51.92% 49.34% 48.07% 49.85% 51.82% 55.22% 51.43% 54.26% 53.79% 57.59% 57.02%
SG&A Expenses to Revenue		 31.37% 31.25% 29.64% 28.53% 35.40% 35.24% 31.75% 30.12% 31.57% 33.27% 34.27%
R&D to Revenue		 10.12% 9.10% 6.44% 6.25% 8.18% 9.42% 6.52% 6.44% 6.18% 6.54% 8.29%
Operating Expenses to Revenue		 41.49% 40.35% 46.52% 43.56% 43.98% 47.04% 38.60% 36.57% 37.74% 39.81% 46.25%
Earnings before Interest and Taxes (EBIT)		 2.58 4.21 3.84 5.04 2.60 -1.23 8.49 11 12 4.30 -2.77
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 3.34 4.81 5.62 6.91 5.80 1.94 12 16 16 9.69 4.02
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.24 1.26 2.29 1.50 1.39 1.53 2.52 1.75 1.72 1.07 0.90
Price to Tangible Book Value (P/TBV)		 1.35 1.36 9.45 4.52 3.58 3.68 11.78 4.58 2.85 2.49 2.01
Price to Revenue (P/Rev)		 1.15 1.19 1.35 0.82 1.03 1.27 1.63 0.97 1.34 0.81 0.82
Price to Earnings (P/E)		 24.01 17.96 92.38 21.17 26.89 0.00 18.99 13.42 17.70 36.77 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 4.17% 5.57% 1.08% 4.72% 3.72% 0.00% 5.27% 7.45% 5.65% 2.72% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.92 2.12 2.63 1.58 1.43 1.59 2.42 1.68 2.04 1.06 0.90
Enterprise Value to Revenue (EV/Rev)		 0.49 0.48 1.23 0.75 0.97 1.19 1.68 1.03 1.10 0.85 0.79
Enterprise Value to EBITDA (EV/EBITDA)		 5.68 3.98 14.62 8.48 10.11 32.99 12.24 7.72 8.27 11.40 22.38
Enterprise Value to EBIT (EV/EBIT)		 7.34 4.55 21.40 11.62 22.51 0.00 16.78 11.11 11.57 25.70 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 10.28 7.30 89.54 18.79 25.79 0.00 19.43 13.40 15.37 38.91 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 5.42 4.46 11.34 5.35 0.00 19.74 13.14 0.00 8.37 28.92 12.31
Enterprise Value to Free Cash Flow (EV/FCFF)		 6.60 5.49 0.00 0.00 0.00 0.00 0.00 0.00 10.06 0.00 92.80
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.14 0.28 0.08 0.14 0.46 0.32 0.16 0.24 0.14
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.08 0.14 0.39 0.26 0.12 0.17 0.09
Financial Leverage		 -0.70 -0.74 -0.48 -0.17 -0.11 -0.09 0.00 0.09 -0.15 -0.13 0.01
Leverage Ratio		 1.12 1.12 1.37 1.58 1.45 1.36 1.67 1.79 1.52 1.46 1.49
Compound Leverage Factor		 1.12 1.12 1.37 1.58 1.45 1.36 1.65 1.68 1.43 1.18 1.73
Debt to Total Capital		 0.00% 0.00% 12.00% 22.10% 7.80% 11.91% 31.62% 24.30% 13.90% 19.42% 12.55%
Short-Term Debt to Total Capital		 0.00% 0.00% 12.00% 22.10% 0.00% 0.00% 5.11% 4.78% 3.67% 6.05% 5.12%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 7.80% 11.91% 26.50% 19.52% 10.23% 13.37% 7.43%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 88.00% 77.90% 92.20% 88.09% 68.38% 75.70% 86.10% 80.58% 87.45%
Debt to EBITDA		 0.00 0.00 0.95 1.76 0.65 3.11 2.18 1.34 0.95 2.48 3.70
Net Debt to EBITDA		 0.00 0.00 -1.41 -0.82 -0.66 -2.18 0.36 0.40 -1.81 0.44 -0.79
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.65 3.11 1.83 1.08 0.70 1.71 2.19
Debt to NOPAT		 0.00 0.00 5.84 3.90 1.67 -7.10 3.46 2.33 1.76 8.47 -5.70
Net Debt to NOPAT		 0.00 0.00 -8.65 -1.83 -1.68 4.96 0.57 0.70 -3.37 1.49 1.22
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 1.67 -7.10 2.90 1.87 1.30 5.83 -3.38
Altman Z-Score		 9.01 8.23 4.20 3.58 4.43 3.91 3.42 3.67 4.76 2.95 2.60
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 8.44 7.52 2.15 1.66 2.98 3.04 2.08 2.24 3.53 2.47 2.20
Quick Ratio		 7.42 6.72 1.77 1.33 2.02 2.11 1.50 1.29 2.61 1.54 1.12
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 2.87 3.48 -21 -2.71 -1.59 -0.36 -11 -3.31 13 -35 0.97
Operating Cash Flow to CapEx		 583.97% 1,264.90% 1,021.44% 495.48% -1,355.65% 501.23% 1,090.74% -101.76% 1,255.07% 288.60% 448.22%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -125.38 -5.21 19.87 -40.91 2.16
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 121.82 -2.19 23.86 4.52 16.26
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 110.65 -4.34 21.96 2.95 12.63
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.99 0.97 1.27 1.21 0.96 0.88 1.02 1.09 1.01 0.91 0.75
Accounts Receivable Turnover		 8.25 8.23 7.62 6.91 6.11 6.07 6.80 6.19 6.26 5.48 4.11
Inventory Turnover		 5.54 5.52 7.43 6.82 4.59 4.06 4.29 3.58 3.11 3.21 2.22
Fixed Asset Turnover		 32.68 39.13 53.76 36.90 23.62 22.57 33.70 40.15 39.01 34.18 24.65
Accounts Payable Turnover		 18.84 17.43 18.89 20.51 16.67 13.48 13.02 10.86 10.27 11.14 3.36
Days Sales Outstanding (DSO)		 44.25 44.33 47.93 52.80 59.75 60.12 53.69 58.97 58.30 66.57 88.80
Days Inventory Outstanding (DIO)		 65.88 66.16 49.12 53.53 79.55 90.01 85.03 102.00 117.37 113.78 164.26
Days Payable Outstanding (DPO)		 19.37 20.94 19.32 17.80 21.89 27.07 28.03 33.61 35.54 32.76 108.77
Cash Conversion Cycle (CCC)		 90.76 89.56 77.72 88.53 117.40 123.07 110.69 127.36 140.13 147.59 144.29
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 9.87 9.00 31 37 41 40 59 71 66 104 100
Invested Capital Turnover		 3.75 4.26 3.33 2.30 1.56 1.32 1.71 1.80 1.79 1.53 1.11
Increase / (Decrease) in Invested Capital		 -1.03 -0.86 22 5.83 3.87 -0.49 18 12 -4.67 37 -3.58
Enterprise Value (EV)		 19 19 82 59 59 64 142 120 136 111 90
Market Capitalization		 45 48 90 64 62 68 138 114 165 106 93
Book Value per Share		 $3.40 $3.64 $3.77 $4.09 $4.27 $4.25 $5.04 $5.89 $7.92 $8.06 $8.30
Tangible Book Value per Share		 $3.14 $3.39 $0.92 $1.36 $1.66 $1.77 $1.08 $2.25 $4.77 $3.45 $3.72
Total Capital		 36 38 45 55 49 51 80 86 112 124 118
Total Debt		 0.00 0.00 5.36 12 3.79 6.05 25 21 16 24 15
Total Long-Term Debt		 0.00 0.00 0.00 0.00 3.79 6.05 21 17 11 17 8.81
Net Debt		 -26 -29 -7.94 -5.69 -3.82 -4.23 4.15 6.27 -30 4.22 -3.19
Capital Expenditures (CapEx)		 0.60 0.34 0.71 2.21 0.62 0.65 0.99 1.37 1.29 1.32 1.63
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 4.50 4.34 8.65 8.51 8.92 7.83 9.91 23 20 35 31
Debt-free Net Working Capital (DFNWC)		 30 33 22 26 17 18 31 37 66 54 49
Net Working Capital (NWC)		 30 33 17 14 17 18 27 33 61 47 43
Net Nonoperating Expense (NNE)		 -0.02 -0.04 -0.06 0.08 -0.05 0.04 0.05 0.48 -0.51 -0.05 -0.08
Net Nonoperating Obligations (NNO)		 -26 -29 -8.11 -5.87 -3.96 -4.37 4.05 6.17 -30 4.12 -3.19
Total Depreciation and Amortization (D&A)		 0.75 0.60 1.78 1.87 3.19 3.17 3.15 4.73 4.68 5.39 6.80
Debt-free, Cash-free Net Working Capital to Revenue		 11.56% 10.79% 12.94% 10.83% 14.71% 14.55% 11.68% 19.44% 16.48% 26.42% 27.14%
Debt-free Net Working Capital to Revenue		 77.67% 81.91% 32.84% 33.57% 27.26% 33.64% 36.65% 31.91% 53.19% 41.59% 43.00%
Net Working Capital to Revenue		 77.67% 81.91% 24.82% 18.08% 27.26% 33.64% 31.82% 28.40% 49.86% 35.86% 37.67%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.18 $0.26 $0.09 $0.29 $0.22 ($0.09) $0.70 $0.00 $0.82 $0.24 ($0.21)
Adjusted Weighted Average Basic Shares Outstanding		 10.47M 10.31M 10.28M 10.35M 10.37M 10.26M 10.46M 0.00 11.46M 12.15M 12.20M
Adjusted Diluted Earnings per Share		 $0.18 $0.26 $0.09 $0.29 $0.22 ($0.09) $0.68 $0.00 $0.79 $0.24 ($0.21)
Adjusted Weighted Average Diluted Shares Outstanding		 10.49M 10.33M 10.34M 10.38M 10.39M 10.26M 10.73M 0.00 11.78M 12.24M 12.20M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 10.50M 10.40M 10.47M 10.57M 10.43M 10.70M 10.96M 0.00 12.16M 12.37M 12.50M
Normalized Net Operating Profit after Tax (NOPAT)		 1.85 2.62 2.53 3.12 2.49 0.05 7.33 8.94 8.83 2.84 -2.01
Normalized NOPAT Margin		 4.75% 6.51% 3.78% 3.97% 4.10% 0.09% 8.64% 7.65% 7.16% 2.17% -1.77%
Pre Tax Income Margin		 6.64% 10.46% 5.75% 6.42% 4.29% -2.29% 9.90% 8.68% 8.96% 2.64% -2.83%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 95.40 16.98 17.27 5.08 -6.16
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 82.39 14.08 13.00 3.36 -5.79
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 84.24 14.83 15.37 3.52 -9.79
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 71.22 11.93 11.10 1.79 -9.42
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 8.33% 36.79% 6.36% 0.00% 49.18% -8.27% 0.00% 0.00% 0.00% 36.04% 0.00%

Quarterly Metrics And Ratios for inTEST

This table displays calculated financial ratios and metrics derived from inTEST's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 24,326,010.00 12,164,698.00 12,489,642.00 12,516,280.00 - 12,373,276.00 12,492,809.00 12,477,676.00 12,483,433.00 12,495,544.00 12,564,657.00
DEI Adjusted Shares Outstanding		 24,326,010.00 12,164,698.00 12,489,642.00 12,516,280.00 - 12,373,276.00 12,492,809.00 12,477,676.00 12,483,433.00 12,495,544.00 12,564,657.00
DEI Earnings Per Adjusted Shares Outstanding		 0.06 0.05 0.02 0.04 - -0.19 -0.04 -0.08 0.10 0.06 0.04
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -13.95% -6.56% 4.40% -2.16% 31.27% -10.69% -17.24% -13.33% -10.33% 27.21% 25.54%
EBITDA Growth		 -43.60% -53.51% -56.03% -39.57% 2.49% -140.56% -46.89% -76.70% 9.77% 401.12% 75.57%
EBIT Growth		 -57.65% -74.08% -84.50% -72.74% 18.44% -384.47% -184.52% -243.65% -28.24% 140.08% 167.24%
NOPAT Growth		 -69.43% -85.83% -90.59% -79.47% 68.40% -587.30% -348.54% -297.11% -33.62% 138.20% 206.49%
Net Income Growth		 -55.15% -76.50% -91.77% -78.26% 3.37% -451.81% -318.70% -289.49% -17.35% 133.88% 194.23%
EPS Growth		 -63.33% -80.00% -91.67% -78.95% 18.18% -480.00% -300.00% -300.00% -23.08% 131.58% 200.00%
Operating Cash Flow Growth		 106.35% -16.47% -278.10% -31.23% -44.75% 166.75% 86.48% -17.86% -139.51% -159.89% 1,018.46%
Free Cash Flow Firm Growth		 164.13% -297.10% -1,112.23% -2,679.15% -727.10% 88.55% 120.86% 124.84% 113.21% -100.01% -46.13%
Invested Capital Growth		 -6.56% 34.85% 51.83% 57.25% 56.35% 0.83% -7.66% -9.72% -3.44% 6.56% -3.45%
Revenue Q/Q Growth		 -9.88% 6.96% 13.97% -10.94% 20.91% -27.23% 5.61% -6.73% 25.10% 3.24% 4.21%
EBITDA Q/Q Growth		 -28.82% -23.48% -6.16% 18.23% 20.73% -130.28% 222.88% -48.14% 468.83% -16.93% -28.35%
EBIT Q/Q Growth		 -40.54% -46.07% -40.78% 43.53% 158.38% -229.52% 82.40% -143.97% 229.06% -27.65% -70.48%
NOPAT Q/Q Growth		 -50.07% -59.84% -36.91% 62.27% 309.57% -216.22% 67.82% -28.69% 237.93% -33.11% -10.31%
Net Income Q/Q Growth		 -36.10% -54.50% -65.26% 115.22% 203.84% -254.85% 78.40% -86.48% 232.52% -36.52% -39.92%
EPS Q/Q Growth		 -42.11% -54.55% -60.00% 100.00% 225.00% -246.15% 78.95% -100.00% 225.00% -40.00% -33.33%
Operating Cash Flow Q/Q Growth		 -24.23% -55.68% -345.30% 183.48% -39.12% 113.95% -112.43% 607.27% -129.28% -224.36% 290.62%
Free Cash Flow Firm Q/Q Growth		 277.49% -532.70% -51.57% -4.17% 8.22% 92.12% 376.28% 24.02% -51.06% -219.28% 174.41%
Invested Capital Q/Q Growth		 -3.27% 45.90% 13.64% -1.95% -3.82% -6.00% 4.07% -4.14% 2.96% 3.73% -5.70%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 44.65% 43.84% 40.59% 46.29% 39.72% 41.51% 42.56% 41.90% 45.39% 45.47% 40.49%
EBITDA Margin		 10.35% 7.41% 6.10% 8.10% 8.08% -3.36% 3.91% 2.18% 9.90% 7.96% 5.47%
Operating Margin		 3.98% 1.65% 0.99% 1.61% 5.68% -10.82% -3.30% -4.55% 3.89% 2.82% 1.03%
EBIT Margin		 6.16% 3.11% 1.62% 2.60% 5.56% -9.90% -1.65% -4.31% 4.45% 3.12% 0.88%
Profit (Net Income) Margin		 5.22% 2.22% 0.68% 1.64% 4.11% -8.74% -1.79% -3.58% 3.79% 2.33% 1.34%
Tax Burden Percent		 92.91% 84.12% 77.70% 86.99% 83.46% 83.51% 86.28% 76.45% 90.27% 80.76% 190.36%
Interest Burden Percent		 91.10% 84.90% 53.92% 72.21% 88.51% 105.76% 125.65% 108.39% 94.25% 92.43% 79.81%
Effective Tax Rate		 7.09% 15.88% 22.30% 13.01% 16.54% 0.00% 0.00% 0.00% 9.73% 19.24% -90.36%
Return on Invested Capital (ROIC)		 6.62% 1.99% 1.03% 1.93% 7.27% -9.91% -2.65% -3.64% 3.91% 2.73% 2.51%
ROIC Less NNEP Spread (ROIC-NNEP)		 3.03% 48.77% 1.74% 1.12% 9.07% 5.80% 0.31% -9.80% 21.53% 0.78% 6.73%
Return on Net Nonoperating Assets (RNNOA)		 -0.44% 0.31% -0.08% -0.10% -1.19% -0.12% 0.02% -0.16% 0.11% -0.01% -0.33%
Return on Equity (ROE)		 6.18% 2.30% 0.95% 1.83% 6.08% -10.03% -2.63% -3.80% 4.02% 2.72% 2.18%
Cash Return on Invested Capital (CROIC)		 19.61% -22.20% -37.01% -42.09% -40.63% -0.81% 7.15% 8.22% 0.95% -6.23% 5.10%
Operating Return on Assets (OROA)		 6.21% 2.76% 1.35% 2.16% 5.06% -8.21% -1.29% -3.31% 3.34% 2.53% 0.76%
Return on Assets (ROA)		 5.25% 1.97% 0.57% 1.36% 3.74% -7.25% -1.40% -2.74% 2.84% 1.89% 1.15%
Return on Common Equity (ROCE)		 6.18% 2.30% 0.95% 1.83% 6.08% -10.03% -2.63% -3.80% 4.02% 2.72% 2.18%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 7.24% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 1.03 0.41 0.26 0.42 1.74 -2.02 -0.65 -0.84 1.15 0.77 0.69
NOPAT Margin		 3.70% 1.39% 0.77% 1.40% 4.74% -7.57% -2.31% -3.18% 3.51% 2.27% 1.96%
Net Nonoperating Expense Percent (NNEP)		 3.59% -46.78% -0.71% 0.81% -1.80% -15.72% -2.96% 6.16% -17.62% 1.94% -4.22%
Return On Investment Capital (ROIC_SIMPLE)		 0.92% 0.33% 0.20% 0.34% 1.40% -1.68% -0.54% -0.70% 0.97% 0.64% 0.57%
Cost of Revenue to Revenue		 55.35% 56.16% 59.41% 53.71% 60.28% 58.49% 57.44% 58.10% 54.61% 54.53% 59.51%
SG&A Expenses to Revenue		 33.75% 33.55% 30.44% 34.35% 28.12% 38.90% 34.09% 33.90% 30.97% 30.53% 30.31%
R&D to Revenue		 6.92% 6.65% 6.53% 7.21% 5.92% 9.19% 7.98% 8.90% 7.35% 7.64% 7.08%
Operating Expenses to Revenue		 40.67% 42.19% 39.60% 44.68% 34.04% 52.32% 45.86% 46.44% 41.51% 42.65% 39.46%
Earnings before Interest and Taxes (EBIT)		 1.72 0.93 0.55 0.79 2.04 -2.64 -0.46 -1.13 1.46 1.06 0.31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2.89 2.21 2.07 2.45 2.96 -0.90 1.10 0.57 3.25 2.70 1.93
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.72 1.62 1.24 0.91 1.07 0.87 0.89 0.96 0.90 1.63 2.12
Price to Tangible Book Value (P/TBV)		 2.85 4.33 3.28 2.28 2.49 2.06 2.09 2.22 2.01 3.52 4.33
Price to Revenue (P/Rev)		 1.34 1.33 1.01 0.75 0.81 0.68 0.75 0.83 0.82 1.41 1.78
Price to Earnings (P/E)		 17.70 22.43 26.69 32.15 36.77 0.00 0.00 0.00 0.00 288.60 145.60
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 5.65% 4.46% 3.75% 3.11% 2.72% 0.00% 0.00% 0.00% 0.00% 0.35% 0.69%
Enterprise Value to Invested Capital (EV/IC)		 2.04 1.64 1.22 0.92 1.06 0.87 0.89 0.95 0.90 1.63 2.23
Enterprise Value to Revenue (EV/Rev)		 1.10 1.31 1.09 0.81 0.85 0.67 0.74 0.79 0.79 1.41 1.71
Enterprise Value to EBITDA (EV/EBITDA)		 8.27 11.46 11.95 10.31 11.40 12.88 16.05 24.93 22.38 22.35 25.90
Enterprise Value to EBIT (EV/EBIT)		 11.57 17.51 22.05 24.89 25.70 115.31 0.00 0.00 0.00 184.68 128.89
Enterprise Value to NOPAT (EV/NOPAT)		 15.37 25.18 35.39 46.31 38.91 5,773.14 0.00 0.00 0.00 1,424.88 137.18
Enterprise Value to Operating Cash Flow (EV/OCF)		 8.37 10.06 17.10 16.76 28.92 11.66 7.71 8.52 12.31 0.00 39.99
Enterprise Value to Free Cash Flow (EV/FCFF)		 10.06 0.00 0.00 0.00 0.00 0.00 11.90 11.01 92.80 0.00 42.89
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.16 0.25 0.31 0.26 0.24 0.21 0.18 0.16 0.14 0.15 0.12
Long-Term Debt to Equity		 0.12 0.16 0.19 0.17 0.17 0.14 0.12 0.10 0.09 0.08 0.07
Financial Leverage		 -0.15 0.01 -0.05 -0.09 -0.13 -0.02 0.05 0.02 0.01 -0.01 -0.05
Leverage Ratio		 1.52 1.63 1.53 1.51 1.46 1.55 1.54 1.52 1.49 1.47 1.42
Compound Leverage Factor		 1.38 1.38 0.83 1.09 1.30 1.64 1.93 1.64 1.41 1.35 1.13
Debt to Total Capital		 13.90% 20.16% 23.85% 20.41% 19.42% 17.05% 15.21% 14.14% 12.55% 12.85% 10.51%
Short-Term Debt to Total Capital		 3.67% 7.74% 9.18% 6.56% 6.05% 5.74% 5.31% 5.51% 5.12% 6.19% 4.44%
Long-Term Debt to Total Capital		 10.23% 12.42% 14.67% 13.85% 13.37% 11.31% 9.90% 8.63% 7.43% 6.66% 6.07%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 86.10% 79.84% 76.15% 79.59% 80.58% 82.95% 84.79% 85.86% 87.45% 87.15% 89.49%
Debt to EBITDA		 0.95 1.81 2.78 2.68 2.48 3.10 3.28 4.49 3.70 2.02 1.50
Net Debt to EBITDA		 -1.81 -0.16 0.96 0.81 0.44 -0.25 -0.15 -1.16 -0.79 -0.04 -1.12
Long-Term Debt to EBITDA		 0.70 1.11 1.71 1.82 1.71 2.06 2.13 2.74 2.19 1.05 0.86
Debt to NOPAT		 1.76 3.97 8.22 12.02 8.47 1,389.39 -21.17 -8.20 -5.70 128.85 7.93
Net Debt to NOPAT		 -3.37 -0.36 2.85 3.63 1.49 -110.48 0.97 2.12 1.22 -2.39 -5.92
Long-Term Debt to NOPAT		 1.30 2.45 5.06 8.16 5.83 921.63 -13.78 -5.01 -3.38 66.78 4.58
Altman Z-Score		 4.52 3.11 2.70 2.46 2.90 2.63 2.71 2.76 2.69 3.79 4.97
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.53 2.15 2.24 2.26 2.47 2.39 2.42 2.31 2.20 2.22 2.49
Quick Ratio		 2.61 1.27 1.39 1.29 1.54 1.38 1.38 1.14 1.12 1.20 1.52
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 5.70 -25 -37 -39 -36 -2.82 7.79 9.66 4.73 -5.64 4.20
Operating Cash Flow to CapEx		 1,520.13% 610.29% -1,610.76% 841.39% 1,587.12% 2,417.03% -148.92% 857.49% -191.39% -514.75% 1,560.25%
Free Cash Flow to Firm to Interest Expense		 37.22 -176.03 -147.64 -177.69 -152.63 -18.56 65.49 101.74 56.31 -70.52 66.64
Operating Cash Flow to Interest Expense		 30.60 14.82 -20.12 19.40 11.06 36.41 -5.78 36.74 -12.17 -41.44 100.30
Operating Cash Flow Less CapEx to Interest Expense		 28.59 12.39 -21.37 17.10 10.36 34.91 -9.66 32.45 -18.52 -49.49 93.87
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.01 0.89 0.84 0.83 0.91 0.83 0.78 0.77 0.75 0.81 0.86
Accounts Receivable Turnover		 6.26 5.53 4.75 4.97 5.48 5.79 4.55 4.78 4.11 4.72 5.11
Inventory Turnover		 3.11 2.37 2.67 2.55 3.21 2.51 2.49 2.31 2.22 2.34 2.62
Fixed Asset Turnover		 39.01 30.39 31.66 31.62 34.18 27.72 26.43 25.31 24.65 25.78 26.75
Accounts Payable Turnover		 10.27 6.90 9.83 8.32 11.14 5.14 5.58 5.21 3.36 3.74 4.04
Days Sales Outstanding (DSO)		 58.30 66.02 76.86 73.42 66.57 63.03 80.14 76.43 88.80 77.37 71.44
Days Inventory Outstanding (DIO)		 117.37 153.87 136.82 143.09 113.78 145.16 146.32 157.70 164.26 156.28 139.48
Days Payable Outstanding (DPO)		 35.54 52.92 37.14 43.89 32.76 71.06 65.42 70.06 108.77 97.52 90.38
Cash Conversion Cycle (CCC)		 140.13 166.98 176.54 172.62 147.59 137.13 161.04 164.07 144.29 136.13 120.54
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 66 97 110 108 104 98 102 98 100 104 98
Invested Capital Turnover		 1.79 1.44 1.34 1.38 1.53 1.31 1.15 1.14 1.11 1.20 1.28
Increase / (Decrease) in Invested Capital		 -4.67 25 38 39 37 0.80 -8.44 -11 -3.58 6.41 -3.51
Enterprise Value (EV)		 136 159 134 99 111 85 90 93 90 170 219
Market Capitalization		 165 161 123 91 106 86 91 97 93 171 228
Book Value per Share		 $7.92 $8.16 $7.97 $8.02 $8.06 $8.03 $8.21 $8.16 $8.30 $8.36 $8.57
Tangible Book Value per Share		 $4.77 $3.06 $3.01 $3.20 $3.45 $3.40 $3.48 $3.52 $3.72 $3.88 $4.20
Total Capital		 112 124 131 126 124 120 121 119 118 120 120
Total Debt		 16 25 31 26 24 20 18 17 15 15 13
Total Long-Term Debt		 11 15 19 17 17 14 12 10 8.81 7.98 7.30
Net Debt		 -30 -2.25 11 7.77 4.22 -1.62 -0.84 -4.33 -3.19 -0.29 -9.45
Capital Expenditures (CapEx)		 0.31 0.34 0.32 0.51 0.16 0.23 0.46 0.41 0.53 0.64 0.41
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 20 28 37 36 35 28 31 28 31 36 31
Debt-free Net Working Capital (DFNWC)		 66 55 57 54 54 50 50 49 49 51 53
Net Working Capital (NWC)		 61 46 45 45 47 44 44 43 43 44 48
Net Nonoperating Expense (NNE)		 -0.42 -0.25 0.03 -0.07 0.23 0.31 -0.15 0.10 -0.09 -0.02 0.22
Net Nonoperating Obligations (NNO)		 -30 -2.35 11 7.67 4.12 -1.62 -0.84 -4.33 -3.19 -0.29 -9.45
Total Depreciation and Amortization (D&A)		 1.17 1.28 1.52 1.66 0.92 1.74 1.57 1.70 1.79 1.64 1.62
Debt-free, Cash-free Net Working Capital to Revenue		 16.48% 23.13% 29.96% 29.15% 26.42% 22.29% 25.54% 23.88% 27.14% 29.34% 24.18%
Debt-free Net Working Capital to Revenue		 53.19% 45.68% 46.57% 43.89% 41.59% 39.58% 41.36% 41.81% 43.00% 42.30% 41.41%
Net Working Capital to Revenue		 49.86% 37.73% 36.80% 37.11% 35.86% 34.19% 36.08% 36.26% 37.67% 36.17% 37.24%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.12 $0.06 $0.02 $0.04 $0.12 ($0.19) ($0.04) ($0.08) $0.10 $0.06 $0.04
Adjusted Weighted Average Basic Shares Outstanding		 11.46M 12.03M 12.23M 12.19M 12.15M 12.18M 12.22M 12.21M 12.20M 12.25M 12.31M
Adjusted Diluted Earnings per Share		 $0.11 $0.05 $0.02 $0.04 $0.13 ($0.19) ($0.04) ($0.08) $0.10 $0.06 $0.04
Adjusted Weighted Average Diluted Shares Outstanding		 11.78M 12.16M 12.33M 12.25M 12.24M 12.18M 12.22M 12.21M 12.20M 12.42M 12.58M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 12.16M 12.49M 12.52M 12.37M 12.37M 12.49M 12.48M 12.48M 12.50M 12.56M 12.83M
Normalized Net Operating Profit after Tax (NOPAT)		 1.03 0.41 0.26 0.42 1.74 -1.80 -0.50 -0.75 1.34 1.37 0.28
Normalized NOPAT Margin		 3.70% 1.39% 0.77% 1.40% 4.74% -6.75% -1.77% -2.87% 4.07% 4.05% 0.78%
Pre Tax Income Margin		 5.62% 2.64% 0.87% 1.88% 4.92% -10.47% -2.07% -4.68% 4.20% 2.88% 0.71%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 11.24 6.62 2.17 3.60 8.70 -17.35 -3.90 -11.92 17.39 13.21 4.95
NOPAT to Interest Expense		 6.73 2.96 1.03 1.93 7.42 -13.27 -5.45 -8.79 13.71 9.63 10.97
EBIT Less CapEx to Interest Expense		 9.22 4.19 0.92 1.29 8.00 -18.86 -7.78 -16.20 11.04 5.16 -1.48
NOPAT Less CapEx to Interest Expense		 4.72 0.53 -0.22 -0.37 6.72 -14.77 -9.34 -13.07 7.36 1.58 4.54
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 36.66% 36.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

inTEST’s Q2 2026 results show a meaningful recovery in revenue and profitability compared with the year-earlier quarter. Revenue increased to $35.3 million from $28.1 million in Q2 2025, a 25.6% gain. The company also moved from a $503,000 net loss to $474,000 of net income, while diluted EPS improved from a loss of $0.04 to earnings of $0.04. However, performance softened sequentially: revenue rose 4.2% from Q1 2026, but gross profit declined from $15.4 million to $14.3 million and operating income fell from $954,000 to $363,000.

Cash generation improved sharply in Q2 2026. Operating cash flow was $6.3 million, compared with a $3.3 million outflow in Q1 and a $688,000 outflow in Q2 2025. The improvement was driven primarily by a $5.0 million favorable change in operating assets and liabilities. Cash and equivalents increased to $22.1 million from $12.9 million at the end of Q1, although part of the change reflects the release of $2.8 million in restricted cash.

The balance sheet also strengthened during the quarter. Total liabilities declined to $41.4 million from $46.3 million in Q1, while total equity increased to $107.7 million from $104.5 million. Current assets of $79.9 million compared with current liabilities of $32.1 million, producing a current ratio of approximately 2.5. Still, investors should monitor margin pressure, earnings volatility and the company’s sizable goodwill and intangible asset balances, which totaled approximately $54.9 million at the end of Q2 2026.

  • Revenue recovery: Q2 2026 revenue of $35.3 million was up 25.6% year over year and exceeded the $33.9 million reported in Q2 2024.
  • Return to profitability: Net income improved to $474,000 from a $503,000 loss in Q2 2025, following losses in Q1 and Q2 2025 and a larger $938,000 loss in Q3 2025.
  • Strong operating cash flow rebound: Operating cash flow rose to $6.3 million in Q2 2026 from negative cash flow in both Q1 2026 and Q2 2025.
  • Improved liquidity and lower liabilities: Cash and equivalents increased by $9.2 million sequentially, while total liabilities declined by $5.0 million and total equity rose by $3.2 million.
  • Debt reduction: Short-term debt, long-term debt and capital lease obligations totaled approximately $12.7 million in Q2 2026, down from approximately $15.4 million in Q1 2026.
  • Working-capital-driven cash generation: The Q2 operating cash flow gain included a $5.0 million benefit from changes in operating assets and liabilities after a $6.4 million headwind in Q1. Investors should determine whether this improvement is repeatable.
  • Cash-flow data inconsistency: The Q2 2026 income statement reports $474,000 of net income, while the accompanying cash-flow statement begins with a $132,000 net loss. This discrepancy may reflect a classification or reporting issue and warrants review in subsequent filings.
  • Sequential margin compression: Gross margin fell to approximately 40.5% in Q2 2026 from 45.5% in Q1, as cost of revenue increased faster than revenue.
  • Operating profitability remains thin: Q2 operating income was only $363,000, or roughly 1.0% of revenue, compared with $1.3 million in Q4 2025 and $2.5 million in Q3 2023.
  • Balance-sheet asset concentration: Goodwill and intangible assets represented approximately 37% of total assets in Q2 2026, increasing the importance of future operating performance and the risk of impairment charges.
10/14/26 03:12 PM ETAI Generated. May Contain Errors.

inTEST Financials - Frequently Asked Questions

According to the most recent income statement we have on file, inTEST's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

inTEST's net income appears to be on an upward trend, with a most recent value of -$2.53 million in 2025, compared with $1.86 million in 2015. The previous period was $2.89 million in 2024. See where experts think inTEST is headed by visiting inTEST's forecast page.

inTEST's total operating income in 2025 was -$3.73 million, based on the following breakdown:
  • Total Gross Profit: $48.92 million
  • Total Operating Expenses: $52.65 million

Over the last 10 years, inTEST's total revenue changed from $38.89 million in 2015 to $113.83 million in 2025, a change of 192.7%.

In the past 11 quarters, inTEST's cash and equivalents has ranged from $12.87 million in Q1 2026 to $41.69 million in Q3 2023, and is currently $22.10 million as of their latest financial filing in Q2 2026.

inTEST had total debt of $14.87 million at the end of 2025, a 38.2% decrease from 2024, and none in 2015.

Over the last 10 years, inTEST's book value per share changed from 3.40 in 2015 to 8.30 in 2025, a change of 144.1%.


Related Companies

Financial statements for NYSE:INTT last updated on 8/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
INSANE DRONE FOOTAGE
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...
Paradigm Press | Sponsoredtc pixel
Why Some AI Stocks Already Surged Over 300 Percent
Jason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...
Brownstone Research | Sponsoredtc pixel
My next big call (under $1)
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
Elon's next millionaires start October 24?
SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...
Behind the Markets | Sponsoredtc pixel
Did you grab your copy yet?
Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarte...
Profits Run | Sponsoredtc pixel
Urgent: Invest In ‘Elon’s iPhone’ Before July 22nd
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
If you think you’re late to AI, see this now
Tech leaders like Microsoft's Satya Nadella and Goldman Sachs' David Solomon say AI's infrastructure buildout ...
Weiss Ratings | Sponsoredtc pixel
Buffett's Final Warning: "The Dollar Is Going to Hell"
Do not buy another AI stock until you've seen the arithmetic below. Nvidia is worth about $5.5 trillion. Al...
Decentralized Masters | Sponsoredtc pixel